Preventative drug providing hope for potential Type 1 diabetes patients in Colorado

"How this drug works is that it binds to the t-cell and causes it to go and get re-educated. Instead of being activated and wanting to kill the cells that make insulin, it basically becomes tired and isn't responsive to the beta cells," explained Dr. Kimber Simmons, Associate Professor of Pediatrics at the Barbara Davis Center within the University of Colorado School of Medicine.